HOBOKEN, NJ - As New Jersey prepares to broaden its qualifications for the COVID vaccine, Mayor Ravi Bhalla and the Hoboken Health Department have taken steps to encourage all Hoboken residents ages 16 and up to pre-register through the Hoboken Health Department at Carepoint.

The Hoboken Health Department has opened its pre-registration list to now accept sign-ups for all Hoboken residents ages 16 and up—who will become eligible to receive the vaccine as of Monday, April 19. 

“Getting vaccinated remains a critical part of overcoming the pandemic and keeping our community safe,” said Mayor Bhalla. “The data demonstrates that the Moderna and Pfizer vaccines are safe and effective, and I encourage all residents to get one as soon as an appointment becomes available. I also ask all residents to consider talking to their friends and family, and assist them in signing up for the vaccine as well.” 

Sign Up for Hoboken Newsletter
Our newsletter delivers the local news that you can trust.

Hoboken residents ages 16 and up can now pre-register via www.hobokennj.gov/vaccinesignup, while selecting the category "general public", if they do not meet other currently listed categories. Those pre-registering are encouraged to provide an e-mail address if they have one, to allow for a faster registration process. 

The City will soon begin scheduling vaccine appointments at Carepoint from the pre-registration list for next week. Residents ages 16 and 17 require a parent or guardian to pre-register on their behalf in order to receive a vaccine through the Hoboken Health Department at Carepoint.  

According to the City, the Hoboken Health Department is currently being supplied with 1,170 Pfizer and 300 Moderna vaccines per week from the New Jersey Department of Health. Meanwhile, residents ages 16 and up will soon be able to register for an appointment in other locations including Hudson County’s site in Kearny (https://hudsoncovidvax.org/), and State-run locations(https://covid19.nj.gov/pages/finder).

Experts suspect demand may exceed supply for a period of time after April 19, given the expanded eligibility. That supply will continue to be strained due to the temporary suspension of Johnson & Johnson vaccinations on Tuesday.

“Following guidance from the New Jersey Department of Health, we have temporarily put a pause on homebound vaccinations and clinics with our local pharmacies utilizing Johnson & Johnson doses,” said Mayor Bhalla Tuesday evening. “Our Hoboken Health Department has been working throughout the day to offer those with Johnson & Johnson vaccine appointments the opportunity to reschedule this week at Carepoint this week utilizing Pfizer vaccines.” 

The move comes following reports, including in the New York Times, of at least six recipients developing a rare disorder involving blood clots within about two weeks of vaccination. No ill effects from any of the three vaccines have been reported in Hudson County, officials told TAPinto. 

The USS Juneau Center in Kearny will continue its operations as scheduled, officials added. Residents who have scheduled an appointment will receive either the Pfizer of Moderna vaccine. 

“After consulting with our own experts, the same ones that have undertaken the absolutely Herculean effort of getting our residents vaccinated as quickly and safely as possible, we have decided that proceeding with caution is our best course of action,” Hudson County Executive Tom DeGise said. “Our vaccination site at the Juneau Center remains open, and all that are coming in for vaccines, either Moderna or Pfizer, should remain confident as they will be under the watchful eyes of the Hudson Regional Health Commission.”

For more information on the CDC and FDA’s decision to temporarily pause Johnson & Johnson vaccine distribution, please click here: https://www.cdc.gov/media/releases/2021/s0413-JJ-vaccine.html

Sign up for TAPinto E-News alerts to be the first to read about all things local!

Download the FREE TAPinto App!  Click here for Android - Click here for iOS for breaking news, traffic/weather alerts and special offers.

Know a story we should share with readers? Email editor Steve Lenox and tell him about it.